UK markets open in 6 hours 39 minutes

Century Therapeutics, Inc. (IPSC)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.9700-0.0300 (-1.00%)
At close: 04:00PM EDT
2.9700 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
4,678
2,235
5,199
0
0
-
Operating expenses
Research development
103,384
92,710
97,173
75,648
39,681
-
Selling general and administrative
29,792
34,706
31,857
19,235
9,495
-
Total operating expenses
133,176
127,416
129,030
94,883
49,176
-
Operating income or loss
-128,498
-125,181
-123,831
-94,883
-49,176
-
Interest expense
1,031
540
1,200
969
289
-
Total other income/expenses net
2,494
-21,748
-10,000
377
-4,018
-
Income before tax
-127,342
-134,792
-130,841
-95,781
-53,575
-
Income tax expense
674
1,881
91
43
-
-
Income from continuing operations
-127,444
-136,673
-130,932
-95,824
-53,575
-
Net income
-127,444
-136,673
-130,932
-95,824
-53,575
-
Net income available to common shareholders
-127,444
-136,673
-130,932
-95,824
-53,575
-
Basic EPS
-2.20
-
-2.27
-2.96
-1.28
-5.88
Diluted EPS
-2.20
-
-2.27
-2.96
-1.28
-5.88
Basic average shares
58,891
-
57,756
32,393
41,804
41,608
Diluted average shares
58,891
-
57,756
32,393
41,804
41,608